PubMed

Predictors of development of diabetes in patients with chronic heart failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) program.

Preiss D, Zetterstrand S, McMurray JJ, Ostergren J, Michelson EL, Granger CB, Yusuf S, Swedberg K, Pfeffer MA, Gerstein HC, Sattar N; Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity Investigators.

Diabetes Care. 2009 May;32(5):915-20. Epub 2009 Feb 5.PMID: 19196892 [PubMed - indexed for MEDLINE]Related articlesFree article

The hemoglobin A1c level as a progressive risk factor for cardiovascular death, hospitalization for heart failure, or death in patients with chronic heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program.

Gerstein HC, Swedberg K, Carlsson J, McMurray JJ, Michelson EL, Olofsson B, Pfeffer MA, Yusuf S; CHARM Program Investigators.

Arch Intern Med. 2008 Aug 11;168(15):1699-704.PMID: 18695086 [PubMed - indexed for MEDLINE]Related articlesFree article

Body mass index and prognosis in patients with chronic heart failure: insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program.

Kenchaiah S, Pocock SJ, Wang D, Finn PV, Zornoff LA, Skali H, Pfeffer MA, Yusuf S, Swedberg K, Michelson EL, Granger CB, McMurray JJ, Solomon SD; CHARM Investigators.

Circulation. 2007 Aug 7;116(6):627-36. Epub 2007 Jul 16. Erratum in: Circulation. 2007 Aug 7;116(6):e136. PMID: 17638930 [PubMed - indexed for MEDLINE]Related articlesFree article

Renal function as a predictor of outcome in a broad spectrum of patients with heart failure.

Hillege HL, Nitsch D, Pfeffer MA, Swedberg K, McMurray JJ, Yusuf S, Granger CB, Michelson EL, Ostergren J, Cornel JH, de Zeeuw D, Pocock S, van Veldhuisen DJ; Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Investigators.

Circulation. 2006 Feb 7;113(5):671-8.PMID: 16461840 [PubMed - indexed for MEDLINE]Related articlesFree article

Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program.

Allen LA, Felker GM, Pocock S, McMurray JJ, Pfeffer MA, Swedberg K, Wang D, Yusuf S, Michelson EL, Granger CB; CHARM Investigators.

Eur J Heart Fail. 2009 Feb;11(2):170-7.PMID: 19168515 [PubMed - indexed for MEDLINE]Related articles

Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program.

Olsson LG, Swedberg K, Ducharme A, Granger CB, Michelson EL, McMurray JJ, Puu M, Yusuf S, Pfeffer MA; CHARM Investigators.

J Am Coll Cardiol. 2006 May 16;47(10):1997-2004. Epub 2006 Apr 27.PMID: 16697316 [PubMed - indexed for MEDLINE]Related articles

Mortality and morbidity reduction with Candesartan in patients with chronic heart failure and left ventricular systolic dysfunction: results of the CHARM low-left ventricular ejection fraction trials.

Young JB, Dunlap ME, Pfeffer MA, Probstfield JL, Cohen-Solal A, Dietz R, Granger CB, Hradec J, Kuch J, McKelvie RS, McMurray JJ, Michelson EL, Olofsson B, Ostergren J, Held P, Solomon SD, Yusuf S, Swedberg K; Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity (CHARM) Investigators and Committees.

Circulation. 2004 Oct 26;110(17):2618-26. Epub 2004 Oct 18.PMID: 15492298 [PubMed - indexed for MEDLINE]Related articlesFree article

Abdominal obesity is an independent risk factor for chronic heart failure in older people.

Nicklas BJ, Cesari M, Penninx BW, Kritchevsky SB, Ding J, Newman A, Kitzman DW, Kanaya AM, Pahor M, Harris TB.

J Am Geriatr Soc. 2006 Mar;54(3):413-20.PMID: 16551307 [PubMed - indexed for MEDLINE]Related articles

Predictors of decreased renal function in patients with heart failure during angiotensin-converting enzyme inhibitor therapy: results from the studies of left ventricular dysfunction (SOLVD)

Knight EL, Glynn RJ, McIntyre KM, Mogun H, Avorn J.

Am Heart J. 1999 Nov;138(5 Pt 1):849-55.PMID: 10539815 [PubMed - indexed for MEDLINE]Related articles

Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program.

Ducharme A, Swedberg K, Pfeffer MA, Cohen-Solal A, Granger CB, Maggioni AP, Michelson EL, McMurray JJ, Olsson L, Rouleau JL, Young JB, Olofsson B, Puu M, Yusuf S; CHARM Investigators.

Am Heart J. 2006 Jul;152(1):86-92.PMID: 16838426 [PubMed - indexed for MEDLINE]Related articles

Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: assessment of Reduction in Mortality and morbidity (CHARM) program.

Ducharme A, Swedberg K, Pfeffer MA, Cohen-Solal A, Granger CB, Maggioni AP, Michelson EL, McMurray JJ, Olsson L, Rouleau JL, Young JB, Yusuf S.

Am Heart J. 2006 May;151(5):985-91. Erratum in: Am Heart J. 2006 Aug;152(2):354. PMID: 16644318 [PubMed - indexed for MEDLINE]Related articles

Weight loss and mortality risk in patients with chronic heart failure in the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme.

Pocock SJ, McMurray JJ, Dobson J, Yusuf S, Granger CB, Michelson EL, Ostergren J, Pfeffer MA, Solomon SD, Anker SD, Swedberg KB.

Eur Heart J. 2008 Nov;29(21):2641-50. Epub 2008 Sep 26.PMID: 18819960 [PubMed - indexed for MEDLINE]Related articlesFree article

Congestive heart failure in type 2 diabetes: prevalence, incidence, and risk factors.

Nichols GA, Hillier TA, Erbey JR, Brown JB.

Diabetes Care. 2001 Sep;24(9):1614-9.PMID: 11522708 [PubMed - indexed for MEDLINE]Related articlesFree article

Incidence and predictors of hyperkalemia in patients with heart failure: an analysis of the CHARM Program.

Desai AS, Swedberg K, McMurray JJ, Granger CB, Yusuf S, Young JB, Dunlap ME, Solomon SD, Hainer JW, Olofsson B, Michelson EL, Pfeffer MA; CHARM Program Investigators.

J Am Coll Cardiol. 2007 Nov 13;50(20):1959-66. Epub 2007 Oct 29.PMID: 17996561 [PubMed - indexed for MEDLINE]Related articles

Systolic blood pressure, diastolic blood pressure, and pulse pressure as predictors of risk for congestive heart failure in the Framingham Heart Study.

Haider AW, Larson MG, Franklin SS, Levy D; Framingham Heart Study.

Ann Intern Med. 2003 Jan 7;138(1):10-6.PMID: 12513039 [PubMed - indexed for MEDLINE]Related articlesFree article

Electrocardiographic strain pattern and prediction of new-onset congestive heart failure in hypertensive patients: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) study.

Okin PM, Devereux RB, Nieminen MS, Jern S, Oikarinen L, Viitasalo M, Toivonen L, Kjeldsen SE, Dahlöf B; LIFE Study Investigators.

Circulation. 2006 Jan 3;113(1):67-73. Epub 2005 Dec 19.PMID: 16365195 [PubMed - indexed for MEDLINE]Related articlesFree article

Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure: results of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Program.

O'Meara E, Clayton T, McEntegart MB, McMurray JJ, Lang CC, Roger SD, Young JB, Solomon SD, Granger CB, Ostergren J, Olofsson B, Michelson EL, Pocock S, Yusuf S, Swedberg K, Pfeffer MA; CHARM Committees and Investigators.

Circulation. 2006 Feb 21;113(7):986-94. Epub 2006 Feb 13.PMID: 16476847 [PubMed - indexed for MEDLINE]Related articlesFree article

Candesartan cilexetil: a pharmacoeconomic review of its use in chronic heart failure and hypertension.

Plosker GL, Keam SJ.

Pharmacoeconomics. 2006;24(12):1249-72. Review.PMID: 17129078 [PubMed - indexed for MEDLINE]Related articles

Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure.

Kistorp C, Faber J, Galatius S, Gustafsson F, Frystyk J, Flyvbjerg A, Hildebrandt P.

Circulation. 2005 Sep 20;112(12):1756-62. Epub 2005 Sep 12.PMID: 16157772 [PubMed - indexed for MEDLINE]Related articlesFree article

Cardiovascular and metabolic predictors of progression of prehypertension into hypertension: the Strong Heart Study.

De Marco M, de Simone G, Roman MJ, Chinali M, Lee ET, Russell M, Howard BV, Devereux RB.

Hypertension. 2009 Nov;54(5):974-80. Epub 2009 Aug 31.PMID: 19720957 [PubMed - indexed for MEDLINE]Related articles